Back to search
FDAFDA · Food and drugs·Recall number D-688-2013

Folic Acid Injection, USP, 5 mg/mL, For IM, IV or SC Use, 10 mL, Multiple Dose Vial, Rx only, APP Pharmaceuticals, LLC, Schaumburg, IL 60173, NDC 63323-184-11

Published July 17, 2013 · Recall initiated: May 21, 2013

Summary

FDA records drug Class III recall D-688-2013, published July 17, 2013 and initiated May 21, 2013. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 80,480 vials; Lot: Lot #: 6103883, Exp 10/2013. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specification

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Kabi USA, LLC
Distributor
Nationwide and Puerto Rico
Lot
Lot #: 6103883, Exp 10/2013
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Folic Acid Injection, USP, 5 mg/mL, For IM, IV or SC Use, 10 mL, Multiple Dose Vial, Rx only, APP Pharmaceuticals, LLC, Schaumburg, IL 60173, NDC 63323-184-11 recalled?

Yes. FDA published recall D-688-2013 on July 17, 2013. Reported hazard: Failed Impurities/Degradation Specification

What should I do if I have this product?

Voluntary: Firm initiated · Letter